Sleepiz

Zürich, Switzerland All Switzerland companies → — Founded 2017

Medical Device / Hardware Wearables / RPM

Geriatrics Pulmonology Sleep Medicine

Cardiology AI Wearables & Remote Monitoring (RPM)

Series A

Website Claim this company

Products

Sleepiz One+

Sleepiz

Cardiology AI

Sleepiz One+ is an FDA-cleared contactless remote patient monitoring device that collects biometric data and records vital signs from a patient's bedside, providing comprehensive respiration and heart rate monitoring for chronic conditions.

Contact for pricing

See all 1 product →

About Sleepiz

Sleepiz is a Swiss medical technology company that develops AI-based, contactless monitoring devices for sleep and vital parameters. Their flagship product, the Sleepiz One+, is a Class IIa CE-marked medical device (Europe) and has received FDA Class II 510(k) clearance (US) for vital sign monitoring. The device is designed for home use and is simply placed on a bedside table, operating in a non-contact fashion to measure movements originating from heart contractions, breathing patterns, and body motions with medical-grade accuracy. This technology allows for the diagnosis of sleep disorders, such as sleep apnea, and long-term monitoring of chronic diseases, providing physicians with continuous data rather than relying on single, random measurements.

For physicians, Sleepiz offers a convenient and efficient tool for patient-centric disease management. The device facilitates examinations over several nights in the patient’s natural sleep environment, increasing the validity of the data and reducing patient discomfort associated with traditional wired sleep studies. The collected data is securely transmitted to a cloud platform and analyzed by Sleepiz’s team of experts, providing high-quality data analysis and insightful reports that can be discussed with patients. Sleepiz’s solutions are designed to help identify health issues early, support managing chronic conditions, and enable remote patient monitoring (RPM), with the potential for reimbursement using Current Procedural Terminology (CPT) codes in the US. The company also partners with healthcare organizations and researchers to integrate novel sleep and respiratory parameters into clinical trials, offering new data endpoints for a more comprehensive understanding of patients’ conditions.

Focus Areas

sleep monitoring respiratory disease monitoring contactless vital sign monitoring remote patient monitoring AI in healthcare digital health medical devices

Business Intelligence

Technology

wireless millimeter wave technology, sensor fusion, artificial intelligence, cloud-native

What Physicians Need to Know

Sleep Apnea Diagnosis

Sleepiz offers a contactless, radar-based device (Sleepiz One+) for the diagnosis of sleep apnea, particularly effective for moderate to severe Obstructive Sleep Apnea (OSA). It provides an alternative to traditional polysomnography (PSG), which can be inconvenient and expensive.

Chronic Respiratory Disease Monitoring

The Sleepiz One+ device is cleared by the FDA for contactless remote patient monitoring (RPM) of respiration and heart rate, assisting in the early detection of deterioration in patients with chronic medical conditions, including chronic respiratory diseases.

Contactless Vital Sign Monitoring

Sleepiz specializes in monitoring heart rate, respiration rate, and body motion without physical contact, using radar technology. The device is placed on a bedside table and measures these vital signs through bedding and clothing.

Remote Patient Monitoring (RPM)

Sleepiz provides a remote patient monitoring service that allows for continuous, at-home capture of sleep and vital-sign metrics, accessible to clinicians via a web interface. The Sleepiz One+ is designed for ease of installation and use by patients.

Clinical Trial Data Collection

Sleepiz partners with healthcare research technology companies to integrate contactless sleep and respiratory measurements into clinical trials, providing novel data endpoints and enabling accurate, comfortable, and natural data collection through unobtrusive radar technology.

AI-Driven Sleep Analytics

At the core of Sleepiz's technology is its AI-driven sleep analytics software, which processes radar signals to derive vital sign statistics and comprehensive sleep parameters, including sleep start/end time, efficiency, awakenings, sleep staging, and Apnea-Hypopnea Index (AHI).

Digital Signal Processing & Sensor Fusion

Sleepiz utilizes digital signal processing to transform raw radar signals into meaningful physiological parameters and employs sensor fusion to enhance data accuracy and insights.

Physician Tip

For physicians, Sleepiz offers a convenient, patient-centric solution for diagnosing sleep apnea and continuously monitoring vital signs in chronic respiratory disease patients from their homes, reducing the need for in-clinic visits and cumbersome wearable devices. The FDA-cleared Sleepiz One+ allows for short- and long-term monitoring, providing enhanced insights into disease progression or remission and enabling timely interventions. The device is easy for patients to set up and use, and physicians can reimburse its use through existing CPT codes for remote patient monitoring. The multi-night, at-home examination increases data validity compared to single, in-clinic measurements, and the contactless nature improves patient comfort and compliance. Sleepiz also provides access to comprehensive data and analytics through a web interface, supporting informed decision-making and potentially opening new areas in sleep medicine.

Sleepiz's technology, including its AI-driven sleep analytics and cloud-based data platform, is designed for integration. It offers SDK/API access for partners to integrate vital sign and sleep metrics into their devices with radar chips. The Sleepiz One+ device is also integrated into remote patient monitoring and clinical study platforms, facilitating comprehensive data collection for healthcare professionals and researchers.

At a glance

Founded 2017

HQ Zürich, Switzerland · Switzerland

CEO Soumya Sunder Dash

Funding Series A

Products 1

Visit site

Products by Sleepiz

1 product in the directory

Sleepiz One+

Sleepiz

Cardiology AI

Contact for pricing

What the Web Says

Sleepiz, an ETH Zurich spin-off founded in 2018, develops medical devices for contactless measurement of sleep and breathing-related illnesses. The company aims to improve people's lives by driving the future of healthcare through its innovative, non-contact sleep monitoring solution. Their device, Sleepiz One+, allows for at-home sleep analysis, which has been praised for its ease of use and convenience compared to traditional sleep lab methods.

Overall: Positive

Strengths

Contactless and comfortable sleep monitoring at home.
Easy to use and set up.
Provides detailed and accurate sleep analysis.
Saves time and provides more information than traditional methods.
Clinically validated and a certified medical device.
Excellent customer service and support.

Limitations

No specific cons were found in the provided search results regarding Sleepiz's products or services.
General concerns about at-home sleep tests from Reddit users, not specific to Sleepiz, include potential for over-diagnosis by companies that also sell devices, and lack of raw data access.

Based on reviews from: Galaxus, Sleepiz.com, EIT - European Institute of Innovation and Technology, Trustpilot, MEDICA, PubMed, Reddit

Last updated: 2026-10-04

Videos

News, demos, and interviews about Sleepiz.

Loading videos...

Videos load interactively. If none appear, search YouTube for Sleepiz →

View all on YouTube

Press & Coverage

Medical Device Network

Sleepiz wins FDA clearance for device that measures vitals during sleep

Sleepiz received FDA Class II 510(k) clearance for its Sleepiz One+ device, a contactless monitor that uses radar technology and AI to measure breathing patterns, respiration rate, and heart rate during sleep for sleep apnea screening and vital sign monitoring.

2023-10

MedTech Intelligence

FDA Clears Sleepiz's Contactless Remote Patient Monitoring Device

Sleepiz One+ received FDA 510(k) clearance, allowing its integration into remote patient monitoring and clinical study platforms for comprehensive respiration and heart rate monitoring.

2023-12

Clario

Clario and Sleepiz AG bring innovative sleep and respiratory data collection features to clinical trials

Clario and Sleepiz AG partnered to integrate Sleepiz's contactless monitoring technology into clinical trials, enabling novel data endpoints for sleep and respiratory conditions.

2023-06

PubMed (Scientific Reports)

Clinical validation of a contactless respiration rate monitor

A study published in Scientific Reports validated the Sleepiz One+ contactless respiration monitor for home use during sleep, showing excellent agreement with the thoracic effort belt in measuring instantaneous breathing rate and its statistics.

2023-03

Venturelab

Sleepiz secures EUR 800,000 in funding and joins the largest U.S. telemedicine organization

Sleepiz secured EUR 800,000 in funding as part of a European research project and joined the American Telehealth Association (ATA) to expand its presence in the U.S. telemedicine market.

2022-10

Venture Kick

Sleepiz raises million CHF 6,2 in Series A financing round to launch its sleep apnea monitor in foreign markets

Sleepiz completed the second closing of its Series A financing round, raising an additional 1.8 million Swiss francs, bringing the total investment to 6.2 million Swiss francs, to launch its sleep apnea monitor in foreign markets.

2022-03

startupticker.ch

Sleepiz AG secures USD 1 million

Sleepiz AG received $500K in funding, part of a total of $1M granted for research, from the European Union's Horizon 2020 Eurostars grant to develop novel three-dimensional radar technology for sleep diagnostics in collaboration with Acconeer and the University of Gothenburg.

2021-05

Sleepiz.com

Sleepiz is One of the First Healthcare Start-ups in Switzerland to Achieve ISO 27701 Certification

Sleepiz became one of the first healthcare startups in Switzerland to achieve ISO 27701 certification, highlighting its commitment to data security in an increasingly digitalized healthcare landscape.

2021-07

Frequently Asked Questions

What are Sleepiz's core products and how do they aid in sleep apnea diagnosis and chronic respiratory disease monitoring?

Sleepiz's core product is the Sleepiz One+, a contactless bedside device that uses radar technology to measure vital signs like heart rate, respiration rate, and body motion during sleep. For sleep apnea diagnosis, the device screens patients in their natural sleep environment, providing data that can be evaluated by experts. For chronic respiratory disease monitoring, it offers continuous, remote vital sign tracking to assist in early detection of deterioration and disease progression.

How does Sleepiz ensure the accuracy and reliability of its contactless vital sign monitoring, and what regulatory clearances does it hold?

Sleepiz One+ utilizes wireless millimeter wave technology, digital signal processing, and AI-driven sleep analytics to measure vital signs with medical-grade accuracy. It has been clinically validated against gold-standard polysomnography for sleep parameters, respiration rate, and heart rate, showing high accuracy. The device holds FDA 510(k) clearance in the US and CE IIa certification in the European Union, affirming its compliance as a medical device.

What are the benefits of Sleepiz's remote patient monitoring (RPM) solution for healthcare providers and patients?

For healthcare providers, Sleepiz's RPM solution offers continuous, objective vital sign data, enabling early detection of patient deterioration and informed decision-making, while potentially reducing hospitalizations. Patients benefit from comfortable, unobtrusive monitoring in their own homes, eliminating the need for wearables and reducing the burden of in-clinic visits.

How does Sleepiz support clinical trials and pharmaceutical research with its data collection capabilities?

Sleepiz partners with healthcare research technology companies like Clario to integrate innovative sleep and respiratory data collection into clinical trial workflows. This provides novel, patient-centric, and unobtrusive data endpoints, offering continuous, real-world data from home settings with high participant compliance.

What is Sleepiz's approach to data privacy and security, given the sensitive nature of health information?

Sleepiz prioritizes data protection and information privacy, holding ISO 27001, ISO 27701, and HIPAA certifications. They ensure that patient data is protected to the highest standards, using secure cloud technology and storing information in Swiss data centers, without using cameras or microphones in their devices.

What is the typical pricing model for Sleepiz products and services for healthcare institutions, and what kind of support is offered?

While specific pricing details are not publicly disclosed, Sleepiz's revenue model is primarily based on the sale of its Sleepiz One+ product to healthcare providers, researchers, and clinical trial participants, with transactions structured as direct sales to hospitals and clinics, and potential subscription models for ongoing data services. Physicians in the U.S. can also reimburse the use of the device using CPT codes for remote patient monitoring. Sleepiz offers support for its medical devices and ensures data analysis and reporting for healthcare professionals.

What partnerships and collaborations has Sleepiz established within the healthcare industry?

Sleepiz has formed strategic partnerships with various organizations, including Clario for clinical trial data collection, AIIMS Patna for remote COVID-19 patient monitoring, and DrKure Technologies for remote monitoring services in India. They also collaborate with leading clinics in Switzerland and Europe and are part of European research projects focused on chronic respiratory disorder prediction and management.